Patent:

Virucidal compounds and use thereof

cris.legacyId

310996

cris.virtual.author-scopus

6603088116

cris.virtual.author-scopus

10244557300

cris.virtual.department

SUNMIL

cris.virtual.department

LPDI

cris.virtual.orcid

0000-0003-4635-6080

cris.virtual.orcid

0000-0002-7377-8636

cris.virtual.parent-organization

AVP-R

cris.virtual.parent-organization

VPA-AVP-R

cris.virtual.parent-organization

VPA

cris.virtual.parent-organization

EPFL

cris.virtual.rid

B-1990-2008

cris.virtual.sciperId

196998

cris.virtual.sciperId

294375

cris.virtual.sciperId

253103

cris.virtual.sciperId

291907

cris.virtual.sciperId

265333

cris.virtual.unitId

10021

cris.virtual.unitManager

Correia, Bruno

cris.virtual.unitManager

Crottini, Andrea

cris.virtual.unitManager

Stellacci, Francesco

cris.virtualsource.author-scopus

0ac6c172-cd12-412c-b61a-ce02c7433a9b

cris.virtualsource.author-scopus

f3ea3811-a735-443c-b623-49fbcb6ed5a4

cris.virtualsource.author-scopus

c66834f7-742c-487f-a22d-84537a01c555

cris.virtualsource.author-scopus

45e89a74-dd61-4144-8749-10e2b5f7cb15

cris.virtualsource.author-scopus

3d60dff5-f474-4f55-b576-43b764f91a0a

cris.virtualsource.department

0ac6c172-cd12-412c-b61a-ce02c7433a9b

cris.virtualsource.department

f3ea3811-a735-443c-b623-49fbcb6ed5a4

cris.virtualsource.department

c66834f7-742c-487f-a22d-84537a01c555

cris.virtualsource.department

45e89a74-dd61-4144-8749-10e2b5f7cb15

cris.virtualsource.department

3d60dff5-f474-4f55-b576-43b764f91a0a

cris.virtualsource.orcid

0ac6c172-cd12-412c-b61a-ce02c7433a9b

cris.virtualsource.orcid

f3ea3811-a735-443c-b623-49fbcb6ed5a4

cris.virtualsource.orcid

c66834f7-742c-487f-a22d-84537a01c555

cris.virtualsource.orcid

45e89a74-dd61-4144-8749-10e2b5f7cb15

cris.virtualsource.orcid

3d60dff5-f474-4f55-b576-43b764f91a0a

cris.virtualsource.parent-organization

2e28ebfd-ace7-4495-9fba-1736cc3ad29a

cris.virtualsource.parent-organization

2e28ebfd-ace7-4495-9fba-1736cc3ad29a

cris.virtualsource.parent-organization

2e28ebfd-ace7-4495-9fba-1736cc3ad29a

cris.virtualsource.parent-organization

2e28ebfd-ace7-4495-9fba-1736cc3ad29a

cris.virtualsource.parent-organization

2e28ebfd-ace7-4495-9fba-1736cc3ad29a

cris.virtualsource.rid

0ac6c172-cd12-412c-b61a-ce02c7433a9b

cris.virtualsource.rid

f3ea3811-a735-443c-b623-49fbcb6ed5a4

cris.virtualsource.rid

c66834f7-742c-487f-a22d-84537a01c555

cris.virtualsource.rid

45e89a74-dd61-4144-8749-10e2b5f7cb15

cris.virtualsource.rid

3d60dff5-f474-4f55-b576-43b764f91a0a

cris.virtualsource.sciperId

0ac6c172-cd12-412c-b61a-ce02c7433a9b

cris.virtualsource.sciperId

f3ea3811-a735-443c-b623-49fbcb6ed5a4

cris.virtualsource.sciperId

c66834f7-742c-487f-a22d-84537a01c555

cris.virtualsource.sciperId

45e89a74-dd61-4144-8749-10e2b5f7cb15

cris.virtualsource.sciperId

3d60dff5-f474-4f55-b576-43b764f91a0a

cris.virtualsource.unitId

2e28ebfd-ace7-4495-9fba-1736cc3ad29a

cris.virtualsource.unitManager

7cea022a-8ecc-4480-bfcb-d49de28e2850

cris.virtualsource.unitManager

2e28ebfd-ace7-4495-9fba-1736cc3ad29a

cris.virtualsource.unitManager

6c681c85-4ddf-4b6c-a557-b71e6bb58a8c

datacite.rights

metadata-only

dc.contributor.author

Tapparel Vu, Caroline

dc.contributor.author

Correia, Bruno

dc.contributor.author

Gainza Cirauqui, Pablo

dc.contributor.author

Stevens, Corey Alfred

dc.contributor.author

Stellacci, Francesco

dc.contributor.author

Richter, Lukasz

dc.contributor.author

Olgiati, Francesca

dc.contributor.author

Medaglia, Chiara

dc.date.accessioned

2024-05-06T13:20:41

dc.date.available

2024-05-06T13:20:41

dc.date.created

2024-05-06

dc.date.issued

2024

dc.date.modified

2025-05-28T07:44:09.664957Z

dc.description.abstract

Disclosed herein are peptide-grafted compounds that irreversibly deactivate bacteriophages or influenza virus depending on the peptide and remain safe for bacteria and mammalian cells. The active compounds comprise a core (cyclodextrin or gold nanoparticle) coated with a hydrophobic chain terminated with a peptide selective for bacteriophages or for influenza. Further, said compounds can be used directly inside the environment of the bioreactor, but they are also a safe additive to stocks of antibiotics and expression inducers (such as isopropyl ß-D-1-thiogalactopyranoside, i.e., IPTG), that cannot be autoclaved and are a common source of phage infections. The anti-influenza compound may be used as a drug to be given in therapeutic or prophylactic mode to fight influenza infection.

dc.description.notes

Alternative title(s) : (fr) Composés virucides et leur utilisation

dc.description.sponsorship

AVP-R-TTO

dc.identifier.epo

90738470

dc.identifier.patentno

WO2024086510

dc.identifier.uri

https://infoscience.epfl.ch/handle/20.500.14299/207826

dc.title

Virucidal compounds and use thereof

dc.type

patent

dspace.entity.type

Patent

dspace.legacy.oai-identifier

oai:infoscience.epfl.ch:310996

epfl.curator.email

francois.schmitt@epfl.ch

epfl.lastmodified.email

ludivine.rouiller@epfl.ch

epfl.legacy.itemtype

Patents

epfl.legacy.submissionform

PATENT

epfl.oai.currentset

OpenAIREv4

epfl.patent.date

2024-04-25

epfl.patent.kindcode

A1

epfl.tto

TTO:6.1514

epfl.writtenAt

EPFL

oairecerif.patent.country

WO

Files

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description:

Collections